For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Flamel Ireland Limited

USPTO Granted Patents = 55

CIPO Patents = 26

EPO Patents = 9

Trademarks = 36

Forward Citations = 998

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Jean-François Dubuisson (37 out of 38 patents)

Claire Mégret (37 out of 37 patents)

Hervé Guillard (37 out of 37 patents)

4. Jordan Dubow (13 out of 13 patents)

5. Julien Grassot (10 out of 10 patents)

6. Jordan Dubow (9 out of 9 patents)

7. Cendrine Grangeon (7 out of 7 patents)

8. Catherine Castan (5 out of 15 patents)

9. Florence Guimberteau (3 out of 23 patents)

10. Gauthier Pouliquen (3 out of 8 patents)

11. Alain Constancis (3 out of 10 patents)

12. Rémi Meyrueix (3 out of 10 patents)

13. Heather Kruchowski (3 out of 3 patents)

14. Jenny Reid (3 out of 3 patents)

15. William J Schaefer (3 out of 5 patents)

Core Competencies:

Gamma-Hydroxybutyrate

Pharmacokinetics

Modified Release Formulations

Nightly Dose Packet

Cysteine Composition

Oral Medicinal Products

Controlled-Release Compositions

Multimicrocapsular Form

High-Fat Meal Administration

Improved Pharmacokinetics

Pharmaceutical Compositions

Storage Systems

55 patents: Sort by Forward Citations

1. D1102889 - Nightly dose packet storage set (2025-11-25),

2. 12478604 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-11-25),

3. 12303478 - Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state (2025-05-20),

4. 12295926 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-05-13),

5. 12263151 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-04-01),

6. 12263150 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-04-01),

7. 12257223 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-03-25),

8. 12239625 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-03-04),

9. 12226389 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-02-18),

10. 12226388 - Modified release gamma- hydroxybutyrate formulations having improved pharmacokinetics (2025-02-18),

11. 12226377 - Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state (2025-02-18),

12. 12186298 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-01-07),

13. 12186296 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-01-07),

14. 12167992 - Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state (2024-12-17),

15. 12167991 - Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state (2024-12-17),

Flamel Ireland Limited is a pharmaceutical company focused on developing and commercializing innovative drug delivery systems. With a strong focus on research and development, Flamel Ireland Limited is committed to improving patient outcomes and quality of life through the delivery of novel therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

55 Patents

#33 in Dublin

#58 in Ireland

#12,527 in the World

Dublin, Ireland

Flamel Ireland Limited

Forward Citations = 998

48 inventors:

Jean-François Dubuisson (37 out of 38 patents)

Claire Mégret (37 out of 37 patents)

Hervé Guillard (37 out of 37 patents)

4. Jordan Dubow (13 out of 13 patents)

5. Julien Grassot (10 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…